JP2025507864A5 - - Google Patents

Info

Publication number
JP2025507864A5
JP2025507864A5 JP2024552028A JP2024552028A JP2025507864A5 JP 2025507864 A5 JP2025507864 A5 JP 2025507864A5 JP 2024552028 A JP2024552028 A JP 2024552028A JP 2024552028 A JP2024552028 A JP 2024552028A JP 2025507864 A5 JP2025507864 A5 JP 2025507864A5
Authority
JP
Japan
Prior art keywords
gene
promoter region
cells
transgene
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024552028A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507864A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/063587 external-priority patent/WO2023168341A1/en
Publication of JP2025507864A publication Critical patent/JP2025507864A/ja
Publication of JP2025507864A5 publication Critical patent/JP2025507864A5/ja
Pending legal-status Critical Current

Links

JP2024552028A 2022-03-02 2023-03-02 操作された細胞および使用方法 Pending JP2025507864A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263315579P 2022-03-02 2022-03-02
US202263315581P 2022-03-02 2022-03-02
US63/315,581 2022-03-02
US63/315,579 2022-03-02
US202363442966P 2023-02-02 2023-02-02
US63/442,966 2023-02-02
PCT/US2023/063587 WO2023168341A1 (en) 2022-03-02 2023-03-02 Engineered cells and methods of use

Publications (2)

Publication Number Publication Date
JP2025507864A JP2025507864A (ja) 2025-03-21
JP2025507864A5 true JP2025507864A5 (cg-RX-API-DMAC10.html) 2026-03-09

Family

ID=87884252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024552028A Pending JP2025507864A (ja) 2022-03-02 2023-03-02 操作された細胞および使用方法

Country Status (6)

Country Link
EP (1) EP4486870A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025507864A (cg-RX-API-DMAC10.html)
CN (1) CN119137262A (cg-RX-API-DMAC10.html)
AU (1) AU2023227880A1 (cg-RX-API-DMAC10.html)
CA (1) CA3253740A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023168341A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117030580B (zh) * 2023-09-15 2024-07-16 广州市第一人民医院(广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院) LDNs在坏死性小肠结肠炎诊断中的应用
WO2026123001A2 (en) * 2024-12-06 2026-06-11 Umoja Biopharma, Inc. Lineage-loci engineered cell therapy and related methods of producing and using same
WO2026133125A1 (en) * 2024-12-16 2026-06-25 Janssen Biotech, Inc. T cell-specific promoters and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0716570A4 (en) * 1993-09-03 1997-12-17 Systemix Inc Genetically Modified Human Hematopoietic Stem Cells and Their Offspring
AU2018301667A1 (en) * 2017-07-12 2020-02-06 Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud Foundation Methods and systems for conditionally regulating gene expression
EP4171616A1 (en) * 2020-06-26 2023-05-03 Juno Therapeutics GmbH Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods

Similar Documents

Publication Publication Date Title
US12024717B2 (en) Method for reconstructing immune function using pluripotent stem cells
Brown et al. Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes
JP2021191294A (ja) 多能性幹細胞を用いた免疫機能再建法
EP2841563B1 (en) Method for developing natural killer cells from stem cells
Zhu et al. Concise review: human pluripotent stem cells to produce cell-based cancer immunotherapy
US20240180961A1 (en) Pluripotent stem cell-derived hematopoietic lineages
WO2019106163A1 (en) Reprogramming of genetically engineered primary immune cells
Guo et al. Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cells
JPWO2010027062A1 (ja) B細胞由来iPS細胞およびその用途
CN115087732B (zh) 来自人T细胞来源的iPS细胞的细胞毒性T细胞
US20250368955A1 (en) B cell lineages derived from pluripotent cells
US20250361487A1 (en) Natural killer cell lineages derived from pluripotent cells
US20250375520A1 (en) Production of immune cells
EP4212618A1 (en) Method of producing vdelta1+ t cells
Xiong et al. Immune cell generation from human-induced pluripotent stem cells: current status and challenges
KR20250099776A (ko) 만능 줄기세포 유래 t 세포 집단 및 이의 전구체
WO2024248157A1 (ja) 多能性幹細胞由来cd4陽性t細胞、その製造方法及びその用途
WO2025125443A1 (en) Production of immune cells
WO2024190905A1 (ja) Hpv特異的細胞傷害性t細胞のt細胞受容体又はその機能的断片